Skip to main content
Top
Published in: Respiratory Research 1/2017

Open Access 01-12-2017 | Research

Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease

Authors: Mariann Szabó, Veronika Sárosi, Zoltán Balikó, Kornélia Bodó, Nelli Farkas, Tímea Berki, Péter Engelmann

Published in: Respiratory Research | Issue 1/2017

Login to get access

Abstract

Background

Based on the phenotypic and functional characteristics unconventional T-lymphocytes such as invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells link the innate and adaptive immune responses. Up to now data are scarce about their involvement in pulmonary disorders including chronic obstructive pulmonary disease (COPD). This study explores simultaneously the frequencies of iNKT and MAIT cells in the peripheral blood and sputum of stable and exacerbating COPD patients.

Methods

By means of multicolor flow cytometry frequencies of total iNKT and MAIT cells and their subsets were enumerated in peripheral blood and sputum samples of healthy controls, and COPD patients. In addition, gene expression of TCR for iNKT, MAIT cells, and CD1d, MR1 were assessed by qPCR in the study cohorts.

Results

Percentages of total iNKT and MAIT cells were dramatically dropped in blood, and reduced numbers of iNKT cells were observed in the sputum of COPD patients. Furthermore decreased DN and increased CD4+ iNKT subsets, while increased DN and decreased CD8+ MAIT subpopulations were measured in the blood of COPD patients. Reduced invariant TCR mRNA levels in COPD patients had confirmed these previous findings. The mRNA expression of CD1d and MR1 were increased in stable and exacerbating COPD patients; however both molecules were decreased upon antibiotic and systemic steroid treatments.

Conclusions

Our results support the notion that both invariant T-cell populations are affected in COPD. Further detailed analysis of invariant T cells could shed more light into the complex interactions of these lymphocyte groups in COPD pathogenesis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27.CrossRefPubMed Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27.CrossRefPubMed
2.
go back to reference Barnes PJ, Burney PG, Silverman EK, Celli BR, Vestbo J, Wedzicha JA, et al. Chronic obstructive pulmonary disease. Nat Rev Dis Primers. 2015;1:15076.CrossRefPubMed Barnes PJ, Burney PG, Silverman EK, Celli BR, Vestbo J, Wedzicha JA, et al. Chronic obstructive pulmonary disease. Nat Rev Dis Primers. 2015;1:15076.CrossRefPubMed
3.
go back to reference Bagdonas E, Raudoniute J, Bruzauskaite I, Aldonyte R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. Int J COPD. 2015;10:995–113. Bagdonas E, Raudoniute J, Bruzauskaite I, Aldonyte R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. Int J COPD. 2015;10:995–113.
5.
go back to reference Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41:631–8.CrossRefPubMed Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41:631–8.CrossRefPubMed
6.
go back to reference Clambey ET, Torres RM. Activation or suppression? T-cell immunity in COPD lungs. COPD. 2009;6:84–5.CrossRefPubMed Clambey ET, Torres RM. Activation or suppression? T-cell immunity in COPD lungs. COPD. 2009;6:84–5.CrossRefPubMed
7.
go back to reference Forsslund H, Mikko M, Karimi R, Grunewald J, Wheelock ÅM, Wahlström J, et al. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. Chest. 2014;145:711–22.CrossRefPubMed Forsslund H, Mikko M, Karimi R, Grunewald J, Wheelock ÅM, Wahlström J, et al. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. Chest. 2014;145:711–22.CrossRefPubMed
9.
go back to reference Rijavec M, Volarevic S, Osolnik K, Kosnik M, Korosec P. Natural killer T cells in pulmonary disorders. Respir Med. 2011;105:S20–5.CrossRefPubMed Rijavec M, Volarevic S, Osolnik K, Kosnik M, Korosec P. Natural killer T cells in pulmonary disorders. Respir Med. 2011;105:S20–5.CrossRefPubMed
11.
go back to reference Brozova J, Karlova I, Novák J. Analysis of the phenotype and function of the subpopulations of mucosal-associated invariant T cells. Scand J Immunol. 2016;84:245–51.CrossRefPubMed Brozova J, Karlova I, Novák J. Analysis of the phenotype and function of the subpopulations of mucosal-associated invariant T cells. Scand J Immunol. 2016;84:245–51.CrossRefPubMed
12.
go back to reference Keller AN, Corbett AJ, Wubben JM, McCluskey J, Rossjohn J. MAIT cells and MR1 antigen recognition. Curr Op Immunol. 2017;46:66–74.CrossRef Keller AN, Corbett AJ, Wubben JM, McCluskey J, Rossjohn J. MAIT cells and MR1 antigen recognition. Curr Op Immunol. 2017;46:66–74.CrossRef
13.
go back to reference Illes Z, Shimamura M, Newcombe J, Oka N, Yamamura T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int. Immunol. 2004;16:223–30. Illes Z, Shimamura M, Newcombe J, Oka N, Yamamura T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int. Immunol. 2004;16:223–30.
14.
go back to reference Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol. 2013;171:8–19.CrossRefPubMedPubMedCentral Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol. 2013;171:8–19.CrossRefPubMedPubMedCentral
15.
go back to reference Yamamura T, Sakuishi K, Illes Z, Miyake S. Understanding the behavior of invariant NKT cells in autoimmune disease. J Neuroimmunol. 2007;191:8–15.CrossRefPubMed Yamamura T, Sakuishi K, Illes Z, Miyake S. Understanding the behavior of invariant NKT cells in autoimmune disease. J Neuroimmunol. 2007;191:8–15.CrossRefPubMed
16.
go back to reference Hinks TS, Wallington JC, Williams AP, Djukanović R, Staples KJ, Wilkinson TM. Steroid-induced deficiency of mucosal-associated invariant T cells in the COPD lung: implications for NTHi infection. Am J Respir Crit Care Med. 2016;194:1208–18.CrossRefPubMedPubMedCentral Hinks TS, Wallington JC, Williams AP, Djukanović R, Staples KJ, Wilkinson TM. Steroid-induced deficiency of mucosal-associated invariant T cells in the COPD lung: implications for NTHi infection. Am J Respir Crit Care Med. 2016;194:1208–18.CrossRefPubMedPubMedCentral
17.
go back to reference Kwon YS, Jin HM, Cho YN, Kim MJ, Kang JH, Jung HJ, et al. Mucosal-associated invariant T cell deficiency in chronic obstructive pulmonary disease. COPD. 2016;13:196–202.CrossRefPubMed Kwon YS, Jin HM, Cho YN, Kim MJ, Kang JH, Jung HJ, et al. Mucosal-associated invariant T cell deficiency in chronic obstructive pulmonary disease. COPD. 2016;13:196–202.CrossRefPubMed
18.
go back to reference Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koëter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000;15:109–15.CrossRefPubMed Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koëter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000;15:109–15.CrossRefPubMed
19.
go back to reference Weiszhar Z, Horvath I. Induced sputum analysis: step by step. Breathe. 2013;9:301–6.CrossRef Weiszhar Z, Horvath I. Induced sputum analysis: step by step. Breathe. 2013;9:301–6.CrossRef
20.
go back to reference Hassett DJ, Borchers MT, Panos RJ. Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives. J Microbiol. 2014;52:211–26.CrossRefPubMed Hassett DJ, Borchers MT, Panos RJ. Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives. J Microbiol. 2014;52:211–26.CrossRefPubMed
21.
go back to reference Maio J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17:946–53.CrossRef Maio J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17:946–53.CrossRef
22.
go back to reference Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol. 2004;4:231–7.CrossRefPubMed Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol. 2004;4:231–7.CrossRefPubMed
23.
go back to reference Viale R, Ware R, Maricic I, Chaturvedi V, Kumar V. NKT cell subsets can exert opposing effects in autoimmunity, tumor surveillance and inflammation. Curr Immunol Rev. 2012;8:287–96.CrossRefPubMedPubMedCentral Viale R, Ware R, Maricic I, Chaturvedi V, Kumar V. NKT cell subsets can exert opposing effects in autoimmunity, tumor surveillance and inflammation. Curr Immunol Rev. 2012;8:287–96.CrossRefPubMedPubMedCentral
24.
go back to reference Zhang G, Nie H, Yang J, Ding X, Huang Y, Yu H, et al. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell functions in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol. 2011;301:L975–84.CrossRefPubMed Zhang G, Nie H, Yang J, Ding X, Huang Y, Yu H, et al. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell functions in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol. 2011;301:L975–84.CrossRefPubMed
25.
go back to reference Engelmann P, Farkas K, Kis J, Richman G, Zhang Z, Liew CW, et al. Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol. 2011;23:473–84.CrossRefPubMed Engelmann P, Farkas K, Kis J, Richman G, Zhang Z, Liew CW, et al. Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol. 2011;23:473–84.CrossRefPubMed
26.
go back to reference Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clono typic monoclonal antibody, 6B11. Immunology. 2007;122:1–14.CrossRefPubMedPubMedCentral Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clono typic monoclonal antibody, 6B11. Immunology. 2007;122:1–14.CrossRefPubMedPubMedCentral
27.
go back to reference Chi SY, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YI, et al. Invariant natural killer T cells in chronic obstructive pulmonary disease. Respirology. 2012;17:486–92.CrossRefPubMed Chi SY, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YI, et al. Invariant natural killer T cells in chronic obstructive pulmonary disease. Respirology. 2012;17:486–92.CrossRefPubMed
28.
go back to reference Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB. The burgeoning family of unconventional T cells. Nat Immunol. 2015;16:1114–23.CrossRefPubMed Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB. The burgeoning family of unconventional T cells. Nat Immunol. 2015;16:1114–23.CrossRefPubMed
29.
go back to reference Hodge G, Hodge S. Steroid resistant CD8+CD28null NKT-like proinflammatory cytotoxic cells in chronic obstructive pulmonary disease. Front Immunol. 2016;7:617.CrossRefPubMedPubMedCentral Hodge G, Hodge S. Steroid resistant CD8+CD28null NKT-like proinflammatory cytotoxic cells in chronic obstructive pulmonary disease. Front Immunol. 2016;7:617.CrossRefPubMedPubMedCentral
30.
go back to reference Fairclough L, Urbanowicz RA, Corne J, Lamb JR. Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond). 2008;114:533–41.CrossRef Fairclough L, Urbanowicz RA, Corne J, Lamb JR. Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond). 2008;114:533–41.CrossRef
31.
go back to reference Pichavant M, Rémy G, Bekaert S, Le Rouzic O, Kervoaze G, Vilain E, et al. Oxidative stress-mediated iNKT-cell activation is involved in COPD pathogenesis. Mucosal Immunol. 2014;7:568–78.CrossRefPubMed Pichavant M, Rémy G, Bekaert S, Le Rouzic O, Kervoaze G, Vilain E, et al. Oxidative stress-mediated iNKT-cell activation is involved in COPD pathogenesis. Mucosal Immunol. 2014;7:568–78.CrossRefPubMed
32.
go back to reference Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients. Respir Res. 2010;11:76.CrossRefPubMedPubMedCentral Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients. Respir Res. 2010;11:76.CrossRefPubMedPubMedCentral
33.
go back to reference Tang Y, Li X, Wang M, Zou Q, Zhao S, Sun B, et al. Increased numbersof NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease. Clin Dev Immunol. 2013;2013:721782.PubMedPubMedCentral Tang Y, Li X, Wang M, Zou Q, Zhao S, Sun B, et al. Increased numbersof NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease. Clin Dev Immunol. 2013;2013:721782.PubMedPubMedCentral
34.
go back to reference Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D, et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med. 2007;356:1410–22.CrossRefPubMed Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D, et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med. 2007;356:1410–22.CrossRefPubMed
35.
go back to reference Ammitzbøll C, Börnsen L, Romme Christensen J, Ratzer R, Romme Nielsen B, Søndergaard HB, et al. Smoking reduces circulating CD26hi CD161hi MAIT cells in healthy individuals and patients with multiple sclerosis. J Leukoc Biol. 2017;101:1211–20.CrossRefPubMed Ammitzbøll C, Börnsen L, Romme Christensen J, Ratzer R, Romme Nielsen B, Søndergaard HB, et al. Smoking reduces circulating CD26hi CD161hi MAIT cells in healthy individuals and patients with multiple sclerosis. J Leukoc Biol. 2017;101:1211–20.CrossRefPubMed
36.
go back to reference Lamichhane R, Ussher JE. Expression and trafficking of MHC related protein 1 (MR1). Immunology. 2017;151:270–9.CrossRefPubMed Lamichhane R, Ussher JE. Expression and trafficking of MHC related protein 1 (MR1). Immunology. 2017;151:270–9.CrossRefPubMed
37.
go back to reference Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AG. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J. 2005;25:647–52.CrossRefPubMed Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AG. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J. 2005;25:647–52.CrossRefPubMed
38.
go back to reference Exley MA, Friedlander P, Alatrakchi N, Vriend L, Yue S, Sasada T, et al. Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: a phase I clinical trial. Clin Cancer Res. 2017;23:3510–9.CrossRefPubMed Exley MA, Friedlander P, Alatrakchi N, Vriend L, Yue S, Sasada T, et al. Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: a phase I clinical trial. Clin Cancer Res. 2017;23:3510–9.CrossRefPubMed
39.
go back to reference Keller CW, Freigang S, Lünemann JD. Reciprocal crosstalk between dendritic cells and natural killer T cells: mechanisms and therapeutic potential. Front Immunol. 2017;8:570.CrossRefPubMedPubMedCentral Keller CW, Freigang S, Lünemann JD. Reciprocal crosstalk between dendritic cells and natural killer T cells: mechanisms and therapeutic potential. Front Immunol. 2017;8:570.CrossRefPubMedPubMedCentral
Metadata
Title
Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease
Authors
Mariann Szabó
Veronika Sárosi
Zoltán Balikó
Kornélia Bodó
Nelli Farkas
Tímea Berki
Péter Engelmann
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2017
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-017-0671-1

Other articles of this Issue 1/2017

Respiratory Research 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine